These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38176112)
1. Expert panel recommendations for topical hemostatic agent use in varied bleeding sites and situations during neuro-spine surgeries. Deopujari CE; Ambekar S; Yetukuri BR; Diyora B; Ghosh A; Krishnan P; Panigrahi M; Ranjan R; Raman C; Tyagi S; Vaishya S; Venkataramana N; Sinha VD; Paniker D; Das S J Clin Neurosci; 2024 Feb; 120():30-35. PubMed ID: 38176112 [TBL] [Abstract][Full Text] [Related]
2. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients. Ramirez MG; Niu X; Epstein J; Yang D J Med Econ; 2018 Oct; 21(10):1041-1046. PubMed ID: 30112922 [TBL] [Abstract][Full Text] [Related]
4. Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes. Ramirez MG; Deutsch H; Khanna N; Cheatem D; Yang D; Kuntze E Hosp Pract (1995); 2018 Oct; 46(4):189-196. PubMed ID: 29986148 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of five standard topical hemostats: a study in porcine liver and spleen models of surgical bleeding. Paternò VA; Bisin A; Addis A BMC Surg; 2020 Sep; 20(1):215. PubMed ID: 32977788 [TBL] [Abstract][Full Text] [Related]
6. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Weaver FA; Hood DB; Zatina M; Messina L; Badduke B Ann Vasc Surg; 2002 May; 16(3):286-93. PubMed ID: 11957004 [TBL] [Abstract][Full Text] [Related]
7. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery. Fiss I; Danne M; Stendel R Neurol Med Chir (Tokyo); 2007 Oct; 47(10):462-7. PubMed ID: 17965563 [TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105 [TBL] [Abstract][Full Text] [Related]
9. Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery. Gazzeri R; Galarza M; Conti C; De Bonis C Neurosurg Rev; 2018 Jan; 41(1):303-310. PubMed ID: 28439721 [TBL] [Abstract][Full Text] [Related]
10. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model. Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Hemostatic Efficacy of Two Powdered Topical Absorbable Hemostats Using a Porcine Liver Abrasion Model of Mild to Moderate Bleeding. MacDonald MH; Tasse L; Wang D; Zhang G; De Leon H; Kocharian R J Invest Surg; 2021 Nov; 34(11):1198-1206. PubMed ID: 32928005 [TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety, and physicochemical properties of a flowable hemostatic agent made from absorbable gelatin sponge via vacuum pressure steam sterilization. Zhou Y; Ma X; Li Z; Wang B J Biomater Appl; 2021 Feb; 35(7):776-789. PubMed ID: 32838612 [TBL] [Abstract][Full Text] [Related]
13. Comparison of a gelatin thrombin versus a modified absorbable polymer as a unique treatment for severe hepatic hemorrhage in swine. Sánchez Del Valle FJ; De Nicolás L; Fernández G; Fernández P; Gómez E; Aranaz Corral I Sci Rep; 2023 Nov; 13(1):20854. PubMed ID: 38012204 [TBL] [Abstract][Full Text] [Related]
14. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding. MacDonald MH; Zhang G; Tasse L; Wang D; De Leon H; Kocharian R J Mater Sci Mater Med; 2021 Sep; 32(10):127. PubMed ID: 34591193 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of a Thrombin-Containing Collagen-Based Hemostatic Agent in Spinal Surgery: A Randomized Clinical Trial. Park SM; Kang DR; Lee JH; Jeong YH; Shin DA; Yi S; Ha Y; Kim KN World Neurosurg; 2021 Oct; 154():e215-e221. PubMed ID: 34246825 [TBL] [Abstract][Full Text] [Related]
16. An Efficacy Comparison of Two Hemostatic Agents in a Porcine Liver Bleeding Model: Gelatin/Thrombin Flowable Matrix versus Collagen/Thrombin Powder. Slezak P; Keibl C; Redl H; Labahn D; Gulle H J Invest Surg; 2020 Oct; 33(9):828-838. PubMed ID: 30907197 [No Abstract] [Full Text] [Related]
17. Topical Hemostatic Agents at Time of Obstetric and Gynecologic Surgery: ACOG Committee Opinion, Number 812. American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice Obstet Gynecol; 2020 Oct; 136(4):e81-e89. PubMed ID: 32976379 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. Lewis KM; Atlee HD; Mannone AJ; Dwyer J; Lin L; Goppelt A; Redl H J Invest Surg; 2013 Jun; 26(3):141-8. PubMed ID: 23514063 [TBL] [Abstract][Full Text] [Related]
19. The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis. Bochicchio GV; Gupta N; Porte RJ; Renkens KL; Pattyn P; Topal B; Troisi RI; Muir W; Chetter I; Gillen DL; Zuckerman LA; Frohna PA J Am Coll Surg; 2015 Jan; 220(1):70-81. PubMed ID: 25458801 [TBL] [Abstract][Full Text] [Related]
20. Topical Hemostatic Agents at Time of Obstetric and Gynecologic Surgery: ACOG Committee Opinion Summary, Number 812. Obstet Gynecol; 2020 Oct; 136(4):870-871. PubMed ID: 32976377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]